Earnings Ahead

EW - Edwards Lifesciences Corp.

90.19 0.7 0.78

  1. Home
  2. Healthcare
  3. EW
Edwards Lifesciences Corp.

Edwards Lifesciences Corp.

About

Profile

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

Headquarters

Irvine, California, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

EW



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Edwards Lifesciences Q4 2023 Earnings Preview
  • Edwards stock jumps 8% on FDA approval, Wells Fargo upgrade
  • Edwards gets FDA okay for Evoque tricuspid valve replacement system
  • Stryker, Boston Scientific fuel MedTech gains
  • Top high-quality growth stocks poised to outperform - MS
  • Buy vs. Sell ideas paired by sector - Oppenheimer
  • Top overweight stocks with high growth and low volume - MS
  • Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback
  • Edwards Lifesciences slips as Wolfe downgrades on emerging rivalry
  • Goldman Sachs 2024 stock strategy - sales growth
  • M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey
  • MedTech stocks gain after Novo Nordisk data for weight loss therapy
  • UBS’s top crowded longs and shorts in MedTech
  • Edwards Lifesciences Non-GAAP EPS of $0.59 in-line, revenue of $1.48B in-line
  • Edwards Lifesciences Q3 2023 Earnings Preview
  • Edwards Lifesciences posts 5-year data for Sapien 3 heart valve
  • SunPower flips to positive despite two downgrades to Sell
  • Citi opens downside catalyst watch on Edwards ahead of Q3 earnings report
  • Edwards Lifesciences said to be the target of EU antitrust raid last week
  • Oppenheimer upgrades Edwards to outperform, citing TTVR opportunity

Earnings History

Date EPS / Forecast Revenue / Forecast
January 26, 2022 0.51 / 0.5473 1.33B / 1.36B
October 27, 2021 0.54 / 0.5326 1.31B / 1.32B
July 29, 2021 0.64 / 0.5548 1.38B / 1.28B Beat!
April 20, 2021 0.54 / 0.4727 1.22B / 1.16B Beat!
January 27, 2021 0.5 / 0.5301 1.19B / 1.18B Beat!
October 21, 2020 0.51 / 0.4429 1.14B / 1.08B Beat!
July 23, 2020 0.34 / 0.19 925M / 793.92M Beat!
April 23, 2020 0.5033 / 0.44 1.13B / 1.08B Beat!
February 11, 2020 - / 1.49 - / 1.15B
January 30, 2020 1.46 / 1.49 1.17B / 1.14B Beat!
October 23, 2019 1.41 / 1.22 1.09B / 1.04B Beat!
July 23, 2019 1.38 / 1.33 1.09B / 1.05B Beat!
April 23, 2019 1.32 / 1.22 993M / 989.25M Beat!
January 31, 2019 1.17 / 1.17 982.7M / 976.32M Beat!
October 23, 2018 1.07 / 1.02 921M / 927.93M
July 26, 2018 1.24 / 1.13 972.1M / 968.48M Beat!
April 24, 2018 1.22 / 1.11 937.5M / 932.33M Beat!